Lantheus to Present at the Jefferies London Healthcare Conference

Rhea-AI Summary

Lantheus Holdings (NASDAQ: LNTH) announced that CFO Bob Marshall will present at the Jefferies London Healthcare Conference on November 16, 2022, at 8:00 a.m. GMT (3 a.m. EST). The live webcast can be accessed on the company's website, with a replay available for 30 days post-presentation. Lantheus has over 65 years of experience in improving patient outcomes through diagnostics, radiotherapeutics, and AI solutions, aimed at helping clinicians Find, Fight, and Follow disease. The company is based in Massachusetts, with additional offices in New Jersey, Canada, and Sweden.

News Market Reaction – LNTH

-2.10%

-2.10% Session move

In the trading session that priced this news, LNTH declined 2.10%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NORTH BILLERICA, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (“the Company”) (NASDAQ: LNTH), a company committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease, today announced Bob Marshall, Chief Financial Officer and Treasurer, will present at the Jefferies London Healthcare Conference at 8:00 a.m. GMT (3 a.m. EST) on Wednesday, November 16.

To access a live webcast of the presentation, please visit the Investors section of the Company’s website at www.lantheus.com. A replay of the webcast will be available on the Company’s website for at least 30 days following the live presentation.

About Lantheus
With more than 65 years of experience in delivering life-changing science, Lantheus is committed to improving patient outcomes through diagnostics, radiotherapeutics and artificial intelligence solutions that enable clinicians to Find, Fight and Follow disease. Lantheus is headquartered in Massachusetts and has offices in New Jersey, Canada and Sweden. For more information, visit www.lantheus.com. 

Contacts:
Mark Kinarney
Vice President, Investor Relations
978-671-8842
ir@lantheus.com 

Melissa Downs
Senior Director, Corporate Communications
646-975-2533
media@lantheus.com 

FAQ

When will Lantheus Holdings present at the Jefferies London Healthcare Conference?

Lantheus Holdings will present on November 16, 2022, at 8:00 a.m. GMT (3 a.m. EST).

How can I access the webcast for Lantheus Holdings' conference presentation?

The live webcast for Lantheus Holdings' conference presentation can be accessed on their website in the Investors section.

What is Lantheus Holdings' focus in healthcare?

Lantheus Holdings focuses on improving patient outcomes through diagnostics, radiotherapeutics, and AI solutions.

What is the stock symbol for Lantheus Holdings?

The stock symbol for Lantheus Holdings is LNTH.

Where is Lantheus Holdings headquartered?

Lantheus Holdings is headquartered in North Billerica, Massachusetts.